Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-293655
Filing Date
2025-11-24
Accepted
2025-11-24 16:03:10
Documents
1
Period of Report
2025-11-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7721
  Complete submission text file 0001193125-25-293655.txt   9315
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Fox Christine (Reporting) CIK: 0001998173 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 251512829